Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Silverback Therapeutics, Inc. | Chief Medical Officer | Common Stock | 54.4K | $206K | $3.78 | May 2, 2022 | Direct |
Silverback Therapeutics, Inc. | Chief Medical Officer | Stock Option (right to buy) | 86.4K | May 2, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SPRY | Silverback Therapeutics, Inc. | May 2, 2022 | 2 | $0 | 4 | May 4, 2022 | Chief Medical Officer |
SPRY | Silverback Therapeutics, Inc. | Feb 1, 2022 | 3 | $0 | 4 | Feb 2, 2022 | Chief Medical Officer |